Detalhe da pesquisa
1.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37940409
2.
Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial.
Eur J Neurol
; 31(1): e16045, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37584095
3.
Translation and cross-cultural adaptation of Polish version of Neuropathic Pain Questionnaire (NPQ-PL) and its comparisons with different questionnaires.
Neurol Neurochir Pol
; 58(1): 66-74, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38175147
4.
External quality monitoring facilitates improvement in already well-performing stroke units: insights from RES-Q Poland.
Neurol Neurochir Pol
; 58(1): 75-83, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38037889
5.
Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland.
Neurol Neurochir Pol
; 58(1): 112-119, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38251955
6.
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin.
Med Res Rev
; 43(5): 1668-1700, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37052231
7.
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
J Peripher Nerv Syst
; 28(3): 436-449, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37314318
8.
Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic.
Neurol Neurochir Pol
; 57(4): 371-378, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37490356
9.
Fluid phase biomarkers in multiple sclerosis.
Curr Opin Neurol
; 35(3): 286-292, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35674070
10.
Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
Int J Neurosci
; 132(10): 1026-1030, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33295845
11.
Onabotulinumtoxin A (ONA-BoNT/A) in the treatment of chronic migraine.
Neurol Neurochir Pol
; 56(1): 39-47, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34477213
12.
Systematic review and network meta-analysis (NMA) for cladribine tablets in achieving sustained disability improvement (SDI) in multiple sclerosis.
Neurol Neurochir Pol
; 56(6): 480-489, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36421066
13.
Cladribine suppresses disease activity in neuromyelitis optica spectrum disorder: a 2-year follow-up study.
Eur J Neurol
; 28(9): 3167-3172, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34233064
14.
A Retrospective Analysis of Pain Etiology in Middle-Aged Patients with Peripheral Neuropathy.
Medicina (Kaunas)
; 57(8)2021 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34440993
15.
Internal carotid and vertebral artery dissections - a comparison of clinical, radiological and prognostic characteristics.
Neurol Neurochir Pol
; 55(1): 52-58, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33047785
16.
Direct admission vs. secondary transfer for mechanical thrombectomy: long-term clinical outcomes from a single Polish Comprehensive Stroke Centre.
Neurol Neurochir Pol
; 55(5): 494-498, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34346053
17.
Secondary progressive multiple sclerosis - from neuropathology to definition and effective treatment.
Neurol Neurochir Pol
; 54(5): 384-398, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33058113
18.
Smoking as a risk factor of onset and relapse of Multiple Sclerosis - a review.
Neurol Neurochir Pol
; 54(3): 243-251, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32285433
19.
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.
Neurol Neurochir Pol
; 54(3): 252-258, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32462652
20.
Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
Neurol Neurochir Pol
; 54(2): 125-137, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32083716